Navigation Links
Sundia Appoints Charles D. Maher as Senior Vice President of Sales and Marketing
Date:10/15/2009

SHANGHAI, Oct. 15 /PRNewswire-Asia/ -- Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, announced today that Mr. Charles D. Maher has been appointed Senior Vice President of Sales and Marketing of Sundia.

Prior to joining Sundia, Mr. Maher was Executive Vice President of Global Sales and Marketing of Azopharma Product Development Group, a CRO company in Florida, USA. Azopharma's CRO service scope covers chemical synthesis, analytical, API, preclinical and clinical operations. Mr. Maher was responsible for development and execution of worldwide strategies, and the recruiting and training of business development managers and directors. Mr. Maher previously also worked for Proceryon Biosciences, a CRO company in New York, as Senior Vice President of Business Development for ten years, and for Bio-Rad Laboratories in USA as Director of Sales for eight years.

Mr. Maher has extensive experience in leading many aspects of CRO industry operations, and has accumulated a consistent track record of improving bottom line by growing revenue, reducing costs and maximizing employee productivity through his career.

In his new role in Sundia, Mr. Maher will be responsible for Sundia's business development in global market. Mr. Maher will report directly to Dr. Xiaochuan Wang, Chairman and CEO of Sundia.

"Mr. Maher's past experience is a perfect match to Sundia's business needs. I am very pleased to welcome him to join our team at this very important point of Sundia's development," commented Dr. Xiaochuan Wang. "With the rapid growth of Sundia, we need more experienced and high quality leaders in the company. I have full confidence that our business development team will deliver a outstanding result under the leadership of Mr. Maher."

Mr. Maher had his college education in Miami University with a double major in marketing management and chemistry, and obtained his MBA degree from Ohio State University in USA.

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) based in Shanghai, China. It was founded in Shanghai in 2004 by a group of U.S. pharmaceutical industry veterans to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide.

SOURCE Sundia MediTech Company


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
2. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
3. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
4. Sundias Animal Facility Passed Client and Government Inspection
5. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
6. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
7. Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
8. Sundia in Top 100 Fast-growth Outsourcing Companies in China
9. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai
10. Sundia Welcomes Professional U.S. Delegation
11. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... announced that the CTNext board of directors has formed a Higher Education Entrepreneurship ... working group composed of institution presidents and other high-ranking representatives from 35 higher ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... Do More ... the transition from being a trusted supplier in the weighing industry, to extending its ... extractions, ELISA essays, enzyme reactions, immunoassays, hybridizations and more, allowing for its customers ...
(Date:6/19/2017)... ... ... A colony of healthy honey bees is like a superorganism--individual bees provide ... containing nutrients necessary for growth and survival. Better nutrition gives the colony a strong ... a decline in honey bee health. Sick and weakened bees diminish the colony's resiliency, ...
(Date:6/15/2017)... ... 15, 2017 , ... Cybrexa Therapeutics, a start-up cancer therapeutics ... in the amount of $6 million. An investment vehicle affiliated with HighCape Partners, ... The Series B funding will enable Cybrexa to complete the build-out of its ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):